Adenovirus Based Virotherapy Market Size & Share, by Type (Oncolytic Adenoviruses, Gene Therapy Vectors), End User (Hospitals, Research Institutes, Biopharmaceutical) - Global Supply & Demand Analysis & Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3118
  • Published Date: Nov 24, 2023
  • Report Format: PDF, PPT

Companies Dominating the Adenovirus Based Virotherapy Market

top-features-companies
    • Amgen Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merck & Co., Inc.
    • Novartis International AG
    • Johnson & Johnson
    • Genelux Corporation
    • PsiOxus Therapeutics
    • Oncorus, Inc.
    • SillaJen, Inc.
    • Transgene SA
    • Virttu Biologics Limited

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • In 2022, Merck merged its wholly owned subsidiary Merck Development & Commercialization Inc., a US-based pharmaceutical company, with Merck Pharmaceuticals America Inc., a US-based pharmaceutical company. The merger was aimed at streamlining operations and improving efficiency.
  • In 2022, Merck merged its wholly owned subsidiary Merck Manufacturing Division, a US-based pharmaceutical manufacturing company, with Merck Pharmaceuticals Supply Chain, a US-based pharmaceutical supply chain company. The merger was aimed at streamlining operations and improving efficiency.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3118
  • Published Date: Nov 24, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing demand for healthcare sector is the major factor driving the market growth.

The market size of adenovirus based virotherapy is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024-2036.

The major players in the market Amgen Inc., Merck & Co., Inc., Novartis International AG, Johnson & Johnson, Genelux Corporation, PsiOxus Therapeutics, Oncorus, Inc., and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying